|Bid||56.93 x 100|
|Ask||56.94 x 300|
|Day's Range||55.86 - 57.50|
|52 Week Range||54.66 - 84.88|
|PE Ratio (TTM)||14.13|
|Earnings Date||Feb 5, 2018 - Feb 9, 2018|
|Forward Dividend & Yield||1.85 (3.36%)|
|1y Target Est||68.70|
Amazon.com, Inc. (NASDAQ: AMZN ) poses an existential threat to a host of retailers, and even to companies outside the retail arena. Drug distributor Cardinal Health Inc (NYSE: CAH ) could be one among ...
Cardinal Health Inc. shares declined 3.4% in premarket trade Monday and McKesson Corporation shares declined 2.4% after Morgan Stanley said they were two of the companies most at risk if Amazon expands ...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Services sector is rising.
DUBLIN, Ohio, Nov. 16, 2017 /PRNewswire/ -- Cardinal Health (CAH) today launched its new Opioid Action Program, aimed at helping communities in four of the nation's hardest-hit states across Appalachia combat the opioid epidemic. The pilot program will deliver much needed front-line tools to help prevent opioid abuse and support first responders in Ohio, Kentucky, Tennessee and West Virginia. The Opioid Action Program has four elements, each cited by leading experts as critical to the fight to reduce opioid abuse and casualties.
Shanghai Pharmaceuticals Holding Co has agreed to buy Cardinal Health Inc's China drug distribution business for $557 million, winning a highly competitive auction in a move that will greatly expand its presence nationwide. The deal will also help Shanghai Pharma, China's third largest drug distributor, become a leading importer of foreign medicine into the world's second-largest drug market.
Shanghai Pharmaceuticals Holding Co has agreed to buy Cardinal Health Inc's China drug distribution business for $557 million, winning a highly competitive auction in a move that will greatly expand its presence nationwide. The deal will also help Shanghai Pharma, China's third largest drug distributor, become a leading importer of foreign medicine into the world's second-largest drug market. Including shareholder loans, the deal gives Cardinal's business in mainland China and Hong Kong an enterprise value of $1.2 billion, equivalent to about 15 times its earnings before interest, taxes, depreciation and amortisation (EBITDA) for the year ended June.
Cardinal Health Inc. has sold its distribution business in China to one of the country's largest publicly traded pharmaceutical groups for $1.2 billion, but is keeping a foothold in the country with its higher-margin services. Dublin-based Cardinal was the first of the big three U.S. health care distributors to enter the world's second-largest economy six years ago. It acquired the former Yong Yu and over two years, added smaller companies for a combined $578 million .
Cardinal Health Inc (NYSE: CAH ) is seeing continued margin contraction at its Pharma Distribution segment. An analyst at Argus thinks this trend would continue, pressuring the stock. The Analyst & The ...
Cardinal Health (CAH) will streamline its Chinese operations by disposing pharmaceutical and medical products distribution business in China.
Shanghai Pharmaceuticals Holding Co. is exploring further acquisitions after it beat out global buyout firms to buy Cardinal Health Inc.’s Chinese distribution business in a $1.2 billion deal.
The U.S. pharmaceutical company, which has taken a hit from falling generic-drug prices, is unloading its distribution operations as Beijing tightens oversight of the industry.
DUBLIN, Ohio, Nov. 14, 2017 /PRNewswire/ -- Cardinal Health (CAH) today announced that it has signed a definitive agreement to sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharma") for $1.2 billion. The transaction is expected to close by the end of Cardinal Health's fiscal year, subject to closing conditions and regulatory clearances. The sale includes Cardinal Health's pharmaceutical and medical products distribution business in China.
Nov 15 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd * Says its unit Century Global signs deal to acquire Cardinal Malaysia for about $557 million Source text in Chinese: http://bit.ly/2iWTXfc Further ...
DUBLIN, Ohio, Nov. 14, 2017 /PRNewswire/ -- As an organization that believes cultivating a diverse and inclusive work environment is crucial to corporate success, Cardinal Health earned a perfect score on the 2018 Corporate Equality Index (CEI) and is among those listed as a Best Places to Work for LGBTQ Equality.
Glancy Prongay & Murray LLP announces an investigation on behalf of Cardinal Health, Inc. investors concerning the Company and its officers’ possible violations of federal securities law.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cardinal Health, Inc. Here are 5 ETFs with the largest exposure to CAH-US. Comparing the performance and risk of Cardinal Health, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis Cardinal Health, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Cardinal Health, Inc. – McKesson Corporation, AmerisourceBergen Corporation, Henry Schein, Inc., CVS Health Corporation, Herbalife Ltd., Owens & Minor, Inc., Teleflex Incorporated, Premier Inc. Class A and Rite ... Read more (Read more...)
Stocks that raise their dividend meaningfully every year will make you a lot of money over the long haul… provided they continue to boost their payouts, of course.
Stocks that raise their dividend meaningfully every year will make you a lot of money over the long haul… provided they continue to boost their payouts, of course. Studies by two global investment heavyweights, BlackRock and GMO, have shown that 90% ...
Law Offices of Howard G. Smith announces an investigation on behalf of Cardinal Health, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.
Outgoing Cardinal Health Inc. CEO George Barrett fielded several questions on the company's role and response in the opioid crisis during Wednesday's annual meeting – including from a grieving father and the head of a charity tangentially swept up in one of the lawsuits against the distributor. Annual meetings are generally short, staid affairs for Cardinal (CAH), the Dublin health-care distributor that's Ohio's largest publicly traded company. “Does the company recognize the role they’ve played in helping stimulate the worst drug epidemic in the history of our country?” said Travis Bornstein, president of Teamsters Local 24 in Akron and co-founder of a charity helping families affected by addiction.
DUBLIN, Ohio , Nov. 8, 2017 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that the board of directors approved a regular quarterly dividend of $0.4624 per share, payable Jan. 15, 2018 , to ...